Public trial registry of the CCC-Munich

Trial VOLFI

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
VOLFI
World
Full title
:

An open-label 2:1 randomized phase II study of panitumumab plus FOLFOXIRI or FOLFOXIRI alone as first-line treatment of patients with non-resectable metastatic colorectal cancer and RAS wild-type (AIO KRK 0109)

World
EudraCT number
:
World
Responsible organization
:
Lmu
Indications
Classification Code Description
ICD-10-GM C18.- Bösartige Neubildung des Kolons
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.